Contractor
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
- UEI
- MBT9RXJJ7428
- Parent UEI
- MBT9RXJJ7428
- Resolved by
- uei
- Confidence
- 1.000
Active from Jun 30, 2015 to Aug 5, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75N95021F00001 CHARACTERIZATION OF A NON-PARALYZING BONT-BASED BIOPHARMACEUTICAL FOR THE TREATMENT OF NEUROPATHIC PAIN | Department of Health and Human Services | NM | Sep 24, 2021 | $1,633,884 |
| HHSF223201510001I IGF::OT::IGF, IN VITRO TOXICOLOGY OF TOBACCO AND RELATED PRODUCTS | Department of Health and Human Services | — | Jun 30, 2015 | — |
| 75A50123F61001 BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | Department of Health and Human Services | NM | Jul 17, 2026 | $100,283 |
| 75N93023D00004 EO 14398 | Department of Health and Human Services | — | Jul 15, 2026 | — |
| 75N95024D00027 PHARMACOLOGY STUDIES AND ANIMAL MODEL DEVELOPMENT AND RELATED SERVICES FOR DRUG DEVELOPMENT | Department of Health and Human Services | — | Jul 13, 2026 | — |
| 75N93022D00009 EO 14398 | Department of Health and Human Services | — | Jul 10, 2026 | — |
| 75N92024F00001 GENE THERAPY RESOURCE PROGRAM (GTRP): PHARMACOLOGY AND TOXICOLOGY CORE LABORATORY - TASK AREA A: CORE ADMINISTRATIVE ACTIVITIES | Department of Health and Human Services | NM | Jul 6, 2026 | $3,553 |
| 75N95023F00002 EFFICACY AND SAFETY EVALUATION OF LEAD GENE THERAPY CANDIDATE IN NEUROMUSCULAR JUNCTION (NMJ) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT | Department of Health and Human Services | NM | Sep 29, 2023 | $1,899,147 |
| 75F40119C10161 DEOBLIGATION/CLOSEOUT | Department of Health and Human Services | MD | Jun 16, 2026 | $38,812,829 |
| 75F40123F19002 UPDATE COR AND UPDATE SOW | Department of Health and Human Services | MD | Jun 9, 2026 | $1,251,731 |
| 75F40122F19001 NO COST EXTENSION | Department of Health and Human Services | MD | Jun 1, 2026 | $2,130,022 |
| 75N95020F00001 NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB) | Department of Health and Human Services | NM | Sep 23, 2020 | $5,298,497 |
| 75A50123F61001 RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP]) | Department of Health and Human Services | NM | Mar 3, 2026 | $5,905,018 |
| W81XWH22P0157 ANIMAL MANAGEMENT SYSTEM SOFTWARE/ MAINTENANCE AGREEMENT. | Department of Defense | MD | Apr 16, 2026 | $741,851 |
| 75N93022F00001 TRANSFER, VALIDATION AND QUALIFICATION OF BIOANALYTICAL METHODS FOR DETECTION OF CABOTEGRAVIR AND LEVONORGESTREL IN RAT AND NONHUMAN PRIMATE PLASMA | Department of Health and Human Services | NM | Apr 1, 2026 | $680,219 |
| HT001122D0030 OMNIBUS IV INDEFINITE DELIVERY INDEFINITE QUANTITY CONTRACT FOR MILITARY MEDICAL RESEARCH AND DEVELOPMENT SERVICES | Department of Defense | — | Mar 27, 2026 | — |
| 75N93021D00031 COMPREHENSIVE AND RAPID RESPONSE FOR NIAID RESEARCH PROGRAMS | Department of Health and Human Services | — | Mar 11, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier MBT9RXJJ7428, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.